Endometrioid endometrial adenocarcinoma with psammoma bodies

American Journal of Surgical Pathology

Volumn 21, Issue 4, 1997, Pages 399-406

  Parkash, Vinita ^a,b   Carcangiu, Maria Luisa ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Endometrioid endometrial carcinoma; Psammoma bodies; Uterine papillary

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PSAMMOMA BODY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ENDOMETRIOID; CURETTAGE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; INCLUSION BODIES; MIDDLE AGED;

EID: 0030985547     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199704000-00005     Document Type: Article

References (30)

1. Ambros RA, Ballouk F, Malfetano JH, Ross JS. Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus. Am J Surg Pathol 1994;18:569-75.
2. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992;69:1424-31.
3. Announcements. FIGO stages - 1988 revision. Gynecol Oncol 1988;35:125-7.
4. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study of 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 1992;47:298-305.
5. Cefis F, Carinelli SG, Marzi MM, Senzani FM. Endometrial adenocarcinoma with psammoma bodies. Tumori 1979;65:359-62.
6. Chen JL, Trost DC, Wilkinson EJ. Endometrial papillary adenocarcinomas: two clinicopathologic types. Int J Gynecol Pathol 1985;4:279-88.
7. Czernobilsky B, Silverman BB, Mikuta JJ. Endometrioid carcinoma of the ovary: a clinicopathologic study of 75 cases. Cancer 1970;26:1141-52.
8. Factor S. Papillary adenocarcinoma of the endometrium with psammoma bodies. Arch Pathol 1974;98:201-5.
9. Ferenczy A, Talens M, Zoghby M, Hussain SS. Ultrastructural studies on the morphogenesis of psammoma bodies in ovarian serous neoplasia. Cancer 1977;39:2451-9.
10. Gleeson N, Gonsalves R, Bonnar J. Uterine fibrinolytic enzymes in endometrial cancer. Eur J Gynecol Oncol 1993;4:369-73.
11. Graven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma: prognostic factors and patterns of recurrence. Cancer 1993;71:3697-702.
12. Hameed K, Morgan DA. Papillary adenocarcinoma of the endometrium with psammoma bodies: histology and fine structure. Cancer 1972;29:1326-35.
13. Hendrickson M, Kempson R. Uterine corpus. In: Sternberg SS, ed. Diagnostic surgical pathology. New York: Raven Press, 1992:2142-4.
14. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93-108.
15. Herbold DR, Magrane DM. Calcifications of the benign endometrium. Arch Pathol Lab Med 1986;110:666-9.
16. Highman WJ. Calcified bodies and the intrauterine device. Acta Cytol 1971;15:473-5.
17. Karpas CM, Bridge MF. Endometrial adenocarcinoma with psammomatous bodies. Am J Obstet Gynecol 1963;87:935-41.
18. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium: an analysis of 21 cases. Cancer 1976;37:872-82.
19. Lauchlan SC. Conceptual unity of the mullerian tumor group: a histologic study. Cancer 1968;22:601-10.
20. Lauchlan SC. Papillary carcinoma of the endometrium. Arch Pathol Lab Med 1981;105:615-8.
21. Lee KR, Vacek PM, Belinson JL. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 1994;54:10-8.
22. Livolsi VA. Adenocarcinoma of the endometrium with psammoma bodies. Obstet Gynecol 1977;50:725-8.
23. Mittal KR, Barwick KW. Diffusely infiltrating adenocarcinoma of the endometrium: a subtype with poor prognosis. Am J Surg Pathol 1988;12:754-8.
24. Parkash V, Carcangiu ML. Uterine papillary serous carcinoma after radiation therapy for carcinoma of the cervix. Cancer 1992;69:496-501.
25. Rosenberg P, Blom R, Hogberg T, Simonsen E. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol 1993;51:311-5.
26. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992;16:600-10.
27. Spjut HJ, Kaufman RH, Carrig SS. Psammoma bodies in cervicovaginal smear. Acta Cytol 1964;8:352-5.
28. Tutschka BG, Lauchlan SC. Psammoma bodies in cervicovaginal smears: case report and review of the literature. Acta Cytol 1978;22:507-10.
29. Valicenti JF, Priester SK. Psammoma bodies of benign endometrial origin in cervicovaginal cytology. Acta Cytol 1977;21:550-2.
30. Weaver RJ, Wilson R. Endometrial carcinoma with psammoma bodies in the vaginal smear. Am J Obstet Gynecol 1967;97:869-70.